What prescription should be given for a patient with a known diagnosis of asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Asthma Prescription Management

For a patient with known asthma, prescribe inhaled corticosteroids (ICS) as the cornerstone of long-term control therapy for all persistent asthma, combined with a short-acting beta-agonist (SABA) for quick relief. 1

Stepwise Treatment Algorithm Based on Severity

Step 1: Mild Intermittent Asthma

  • No daily medication required 1
  • Quick-relief: Short-acting inhaled beta-agonist (albuterol/salbutamol) as needed 1
  • Use 2 puffs via spacer, repeat 10-20 times if no nebulizer available 1

Step 2: Mild Persistent Asthma

  • Preferred daily medication: Low-dose inhaled corticosteroids 1
  • Alternative options (not preferred): Cromolyn, leukotriene modifiers (montelukast/zafirlukast), or nedocromil 1
  • Quick-relief: Short-acting beta-agonist as needed 1

Step 3: Moderate Persistent Asthma

  • Preferred: Low-to-medium dose ICS + long-acting beta-agonist (LABA) 1
  • Alternative for children <5 years: Medium-dose ICS alone 1
  • Quick-relief: Short-acting beta-agonist as needed 1

Step 4-5: Severe Persistent Asthma

  • High-dose ICS + LABA 1
  • Consider adding omalizumab (anti-IgE) for patients ≥12 years with allergen sensitivity requiring step 5-6 care 1
  • If needed: Add oral corticosteroids 1
  • Quick-relief: Short-acting beta-agonist as needed; oral steroids may be required 1

Acute Exacerbation Management

Mild Exacerbation (PEF >50% predicted, normal speech, pulse <110, respirations <25)

  • Nebulized salbutamol 5 mg or terbutaline 10 mg 1
  • If PEF 50-75% after 15-30 minutes: Give prednisolone 30-60 mg 1, 2
  • If PEF >75%: Step up usual treatment 1
  • Follow-up within 48 hours 1

Moderate-Severe Exacerbation (PEF <50%, can't complete sentences, pulse >110, respirations >25)

  • Oxygen 40-60% to maintain SpO2 >92% 1
  • Nebulized salbutamol 5 mg or terbutaline 10 mg with oxygen-driven nebulizer 1
  • Prednisolone 30-60 mg orally (preferred route) 1, 2
  • Alternative if vomiting/severe: IV hydrocortisone 200 mg, then 200 mg every 6 hours 1, 2
  • Add ipratropium 0.5 mg to nebulizer if not improving after 15-30 minutes 1
  • Monitor response 15-30 minutes after treatment 1

Systemic Corticosteroid Dosing for Exacerbations

Adults:

  • 40-60 mg prednisone daily for 5-10 days without tapering 2
  • Continue until PEF reaches 70% of predicted or personal best 2
  • Oral route equally effective as IV and strongly preferred 2

Children:

  • 1-2 mg/kg/day prednisone (maximum 60 mg/day) in 2 divided doses for 3-10 days 2
  • No tapering needed for courses <7-10 days, especially if on inhaled corticosteroids 2

Monitoring Beta-Agonist Use

Critical pitfall: If using more than one canister of short-acting beta-agonist per month, increase daily long-term control therapy immediately 1. This indicates inadequate asthma control and increased risk of exacerbation 1.

Essential Concurrent Management

Comorbidity Treatment

  • Allergic rhinitis: Intranasal corticosteroids, antihistamines, consider immunotherapy 1
  • GERD: Avoid heavy meals/caffeine/alcohol within 3 hours of sleep, elevate head of bed 6-8 inches, proton pump inhibitors 1
  • Obstructive sleep apnea: Consider in overweight/obese patients with poorly controlled asthma; treat with CPAP 1

Patient Education Requirements

  • Written asthma action plan detailing when to increase medications, when to call physician, when to seek emergency care 1
  • Peak flow meter with instructions on target values 1
  • Proper inhaler technique verification at every visit 1

Critical Pitfalls to Avoid

  • Never underuse corticosteroids in persistent asthma—this is the most effective anti-inflammatory medication and reduces exacerbations more effectively than any other single agent 1
  • Never delay systemic corticosteroids in moderate-severe exacerbations; anti-inflammatory effects take 6-12 hours to manifest 2, 3
  • Never use sedating medications during acute exacerbations—absolutely contraindicated as they worsen respiratory function 4
  • Never discharge from hospital until PEF >75% predicted, diurnal variability <25%, and nocturnal symptoms resolved 2
  • Never rely solely on clinical impression for severity assessment—always measure PEF or FEV1 objectively 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Corticosteroid Dosing for Asthma Exacerbations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Chapter 14: Acute severe asthma (status asthmaticus).

Allergy and asthma proceedings, 2012

Guideline

Respiratory Safety Concerns with Quetiapine in Asthmatic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.